| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | W980KJ009P |
| InChI Key | OMFXVFTZEKFJBZ-HJTSIMOOSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C21H30O4 |
| Molecular Weight | 346.47 |
| AlogP | 2.67 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 74.6 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 25.0 |
| Primary Target | |
|---|---|
| Glucocorticoid receptor |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Oxidoreductase
|
- | - | - | - | 8-15 | |
|
Membrane receptor
|
- | - | - | 35600 | - | |
|
Secreted protein
|
- | - | 457 | 13-63 | - | |
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 3
Nuclear hormone receptor subfamily 3 group C
Nuclear hormone receptor subfamily 3 group C member 2
|
- | - | 1 | - | - | |
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 3
Nuclear hormone receptor subfamily 3 group C
Nuclear hormone receptor subfamily 3 group C member 4
|
- | 23442 | - | - | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC22 family of organic cation and anion transporters
|
- | - | - | - | 34 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Osteoarthritis, Hip | 3 | D015207 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 50-22-6 |
| ChEBI | 16827 |
| ChEMBL | CHEMBL110739 |
| DrugBank | DB04652 |
| EPA CompTox | DTXSID6022474 |
| FDA SRS | W980KJ009P |
| Human Metabolome Database | HMDB0001547 |
| Guide to Pharmacology | 2869 |
| KEGG | C02140 |
| PDB | C0R |
| PubChem | 5753 |
| SureChEMBL | SCHEMBL22612 |
| ZINC | ZINC000013513592 |